Theranexus Société Anonyme (ALTHX.PA)

EUR 0.39

(0.69%)

Operating Expenses Summary of Theranexus Société Anonyme

  • Theranexus Société Anonyme's latest annual operating expenses in 2023 was 3 Million EUR , down -49.28% from previous year.
  • Theranexus Société Anonyme's latest quarterly operating expenses in 2024 Q2 was 1.18 Million EUR , down 0.0% from previous quarter.
  • Theranexus Société Anonyme reported a annual operating expenses of 5.92 Million EUR in annual operating expenses 2022, up 758.4% from previous year.
  • Theranexus Société Anonyme reported a annual operating expenses of 690.23 Thousand EUR in annual operating expenses 2021, down -12.13% from previous year.
  • Theranexus Société Anonyme reported a quarterly operating expenses of 1.14 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Theranexus Société Anonyme reported a quarterly operating expenses of 7.68 Million EUR for 2023 FY, up 29.73% from previous quarter.

Annual Operating Expenses Chart of Theranexus Société Anonyme (2023 - 2015)

Created with Highcharts 11.1.0YearsOperating Expenses201520162017201820192020202120222023-2000000 EUR0 EUR2000000 EUR4000000 EUR6000000 EUR

Historical Annual Operating Expenses of Theranexus Société Anonyme (2023 - 2015)

Year Operating Expenses Operating Expenses Growth
2023 3 Million EUR -49.28%
2022 5.92 Million EUR 758.4%
2021 690.23 Thousand EUR -12.13%
2020 785.56 Thousand EUR 24.3%
2019 632 Thousand EUR 49.7%
2018 422.18 Thousand EUR -66.01%
2017 1.24 Million EUR 100.49%
2016 619.51 Thousand EUR 20155.65%
2015 -3089.00 EUR 0.0%

Peer Operating Expenses Comparison of Theranexus Société Anonyme

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR 28.059%
ABIVAX Société Anonyme 127.37 Million EUR 97.641%
Adocia SA 15.62 Million EUR 80.773%
Aelis Farma SA 18.81 Million EUR 84.032%
Biophytis S.A. 14.33 Million EUR 79.034%
Advicenne S.A. 8.21 Million EUR 63.421%
genOway Société anonyme 16.73 Million EUR 82.047%
IntegraGen SA 5.35 Million EUR 43.858%
Medesis Pharma S.A. 1.56 Million EUR -92.064%
Neovacs S.A. 10.34 Million EUR 70.948%
NFL Biosciences SA 4.37 Million EUR 31.304%
Plant Advanced Technologies SA 2.76 Million EUR -8.685%
Quantum Genomics Société Anonyme 1.71 Million EUR -74.915%
Sensorion SA 27.05 Million EUR 88.893%
TME Pharma N.V. 5.49 Million EUR 45.334%
Valbiotis SA 9.86 Million EUR 69.551%
TheraVet SA 1.64 Million EUR -82.75%
Valerio Therapeutics Société anonyme 20.32 Million EUR 85.212%
DBV Technologies S.A. 89.4 Million EUR 96.639%
Genfit S.A. 54.8 Million EUR 94.517%
GeNeuro SA 14.35 Million EUR 79.07%
Innate Pharma S.A. 64.57 Million EUR 95.346%
Inventiva S.A. 120.18 Million EUR 97.5%
MaaT Pharma SA 21.59 Million EUR 86.087%
MedinCell S.A. 32.92 Million EUR 90.872%
Nanobiotix S.A. 58.92 Million EUR 94.9%
OSE Immunotherapeutics SA 23.58 Million EUR 87.261%
Poxel S.A. 28.76 Million EUR 89.553%
GenSight Biologics S.A. 32.66 Million EUR 90.799%
Transgene SA 31.23 Million EUR 90.378%
Valneva SE 134.92 Million EUR 97.773%